Literature DB >> 1825072

Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin.

M H Giroix1, J Rasschaert, D Bailbe, V Leclercq-Meyer, A Sener, B Portha, W J Malaisse.   

Abstract

In islets from adult rats injected with streptozocin during the neonatal period, the oxidative and secretory responses to D-glucose are more severely affected than those evoked by L-leucine. A possible explanation for such a preferential defect was sought by comparing the rate of aerobic glycolysis, taken as the sum of D-[3,4-14C]glucose conversion to labeled CO2, pyruvate, and amino acid, with the total glycolytic flux, as judged from the conversion of D-[5-3H]glucose to 3H2O. A preferential impairment of aerobic relative to total glycolysis was found in islets from diabetic rats incubated at either low or high D-glucose concentration. This coincided in islet mitochondria of diabetic rats with a severe decrease in both the basal (no-Ca2+) generation of 3H2O from L-[2-3H]glycerol-3-phosphate and the Ca2(+)-induced increment in [3H]glycerophosphate detritiation. The mitochondria of diabetic rats were also less efficient than those of control animals in generating 14CO2 from [1-14C]-2-ketoglutarate. The diabetes-induced alteration of 2-ketoglutarate dehydrogenase in islet mitochondria was less marked, however, than that of the FAD-linked glycerophosphate dehydrogenase and was not associated with any change in responsiveness to Ca2+. Sonicated islet mitochondria of diabetic rats displayed normal to slightly elevated glutamate dehydrogenase activity. We propose, therefore, that the preferential impairment of the oxidative and secretory responses of islet cells to D-glucose in this experimental model of diabetes may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825072     DOI: 10.2337/diab.40.2.227

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

1.  Decreased mitochondrial gene expression in isolated islets of rats injected neonatally with streptozotocin.

Authors:  N Welsh; S Pääbo; M Welsh
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

Review 2.  Glucose-sensing mechanisms in pancreatic beta-cells.

Authors:  Patrick E MacDonald; Jamie W Joseph; Patrik Rorsman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  Fat-induced changes in mouse pancreatic islet insulin secretion, insulin biosynthesis and glucose metabolism.

Authors:  K Capito; S E Hansen; C J Hedeskov; H Islin; P Thams
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

4.  The role of islet secretory function in the development of diabetes in the GK Wistar rat.

Authors:  S J Hughes; K Suzuki; Y Goto
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

5.  Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes.

Authors:  M J MacDonald; M J Longacre; E-C Langberg; A Tibell; M A Kendrick; T Fukao; C-G Ostenson
Journal:  Diabetologia       Date:  2009-03-19       Impact factor: 10.122

6.  Effect of streptozotocin and nicotinamide upon FAD-glycerophosphate dehydrogenase activity and insulin release in purified pancreatic B-cells.

Authors:  J Rasschaert; Z Ling; W J Malaisse
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

Review 7.  Is type 2 diabetes due to a deficiency of FAD-linked glycerophosphate dehydrogenase in pancreatic islets?

Authors:  W J Malaisse
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Deficient activity of FAD-linked glycerophosphate dehydrogenase in islets of GK rats.

Authors:  C G Ostenson; S M Abdel-Halim; J Rasschaert; F Malaisse-Lagae; S Meuris; A Sener; S Efendic; W J Malaisse
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

9.  Streptozotocin-induced FAD-glycerophosphate dehydrogenase suppression in pancreatic islets. Relationship with the severity and duration of hyperglycaemia and resistance to insulin or riboflavin treatment.

Authors:  J Rasschaert; W J Malaisse
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients.

Authors:  J Fernandez-Alvarez; I Conget; J Rasschaert; A Sener; R Gomis; W J Malaisse
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.